| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 134.26 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Average life expectancy has been increasing, and age is a major risk factor for thromboembolic events [1]. In 2024, Portugal had the second-highest percentage of older people in the European Union [2]. In 2008, direct oral anticoagulants, targeting specific coagulation factors, were introduced [3]. To study the knowledge of the elderly about the safe use of this class of medication and its associated risks. Observational, descriptive, cross-sectional study using a non-probabilistic convenience sample. A questionnaire was applied to individuals aged 65 and over, with questions about the use of direct oral anticoagulants. Total scores were calculated by summing the individual scores obtained for each question (0-10). Variables analyzed included gender, age, education level, duration of treatment and polymedication. Values of p < 0.05 were considered statistically significant. Thirty-one questionnaires were obtained, with an average perception score of 7.23/10 (minimum: 3/10, maximum: 10/10). Participants demonstrated better understanding in recognizing when symptoms are not related to anticoagulants, but had more difficulty identifying situations requiring prior medical advice. In terms of gender, age, duration of treatment and polymedication, there were no differences regarding knowledge. Only the education level showed differences between low and high education groups (p = 0.024). Most participants demonstrated correct knowledge. However, educational programs with accessible materials and clear language remain essential for the elderly. Ongoing monitoring by healthcare professionals is also essential, with regular consultations addressing both clinical control and the patient’s understanding of the treatment.
Descrição
Palavras-chave
Direct oral anticoagulants Elderly knowledge
Contexto Educativo
Citação
Monteiro, J., Silva, S., Oiveira, A. I., & Oliveira, R. F. (2025). Older people’s perception of direct oral anticoagulants. 13th APLF Annual Conference, TherapeuTic advances in drug safety 16(S1), 44. https://journals.sagepub.com/doi/epub/10.1177/20420986251379201
Editora
SAGE Publications
